Feedback / Questions
CK0803 - Cellenkos
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-cellenkos-ck0803-tregs-for-treatment-of-amyotrophic-lateral-sclerosis-302588514.html
Oct 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next